Preclinical metabolism and disposition of SB939 (pracinostat), an orally active histone deacetylase inhibitor, and prediction of human pharmacokinetics

by Jayaraman, R., Reddy, V.P., Pasha, M.K., Wang, H., Sangthongpitag, K., Yeo, P., Hu, C.Y., Wu, X., Xin, L., Goh, E., New, L.S., Ethirajulu, K.
Published 2014

Pharmacodynamic evaluation of the target efficacy of SB939, an oral HDAC inhibitor with selectivity for tumor tissue

by Novotny-Diermayr, V., Sausgruber, N., Loh, Y.K., Pasha, M.K., Jayaraman, R., Hentze, H., Yong, W.-P., Goh, B.-C., Toh, H.-C., Ethirajulu, K., Zhu, J., Wood, J.M.
Published 2014